Indivior Share Price | |
---|---|
Price | 1,408.00 |
Bid | 1,403.00 |
Ask | 1,414.00 |
Change | 8.00 (0.57%) |
Volume | 660,243 |
Open | 1,400.00 |
High | 1,426.00 |
Low | 1,365.00 |
Prev. Close | 1,400.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 135.47m |
Market Capitalisation | £1.91b |
Market Size | 1,500 |
52 Week High | 1,927.00 |
52 Week High Date | 27-Jul-2023 |
52 Week Low | 1,128.00 |
52 Week Low Date | 19-Dec-2023 |
# Trades | 3,833 |
---|---|
Vol. Sold | 140,293 |
Sold Value | £1.96m |
Vol. Bought | 350,357 |
Bought Value | £4.92m |
PE Ratio | 1,792.65774 |
Earnings | 0.785426 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 18:52:38 | 1,387.769 | 980 | Unknown* | 1,403.00 | 1,414.00 | 13.60k | O Ordinary Was reported as OTC |
26-Apr-24 | 14:52:05 | 1,395.00 | 29 | Unknown* | 1,403.00 | 1,414.00 | 404.55 | O Ordinary Delayed publication Was reported as OTC |
26-Apr-24 | 18:09:00 | 1,404.102 | 6,581 | Unknown* | 1,403.00 | 1,414.00 | 92.40k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:08:24 | 1,396.142 | 7,351 | Unknown* | 1,403.00 | 1,414.00 | 102.63k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:06:47 | 1,396.72 | 9,224 | Unknown* | 1,403.00 | 1,414.00 | 128.83k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:00:08 | 1,381.00 | 71 | Unknown* | 1,403.00 | 1,414.00 | 980.51 | O Ordinary Was reported as OTC |
26-Apr-24 | 17:59:29 | 1,408.00 | 4,983 | Unknown* | 1,403.00 | 1,414.00 | 70.16k | O Ordinary Was reported as OTC |
26-Apr-24 | 17:59:29 | 1,408.00 | 1,195 | Unknown* | 1,403.00 | 1,414.00 | 16.83k | O Ordinary Was reported as OTC |
26-Apr-24 | 17:53:31 | 1,386.91 | 107 | Unknown* | 1,403.00 | 1,414.00 | 1,484 | O Ordinary Was reported as OTC |
26-Apr-24 | 14:49:05 | 1,395.00 | 0 | Unknown* | 1,403.00 | 1,414.00 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
18-Mar-24 | 15-Mar-24 | Transfer From | Ryan Preblick held the position of CFO & Executive Director at the time of this trade.Ryan Preblick | 0.00 | 3,920 | 229,089 | |
18-Mar-24 | 18-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,617.00 | GBX | 10,549 | 335,935 |
18-Mar-24 | 15-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,644.00 | GBX | 15,444 | 335,935 |
18-Mar-24 | 14-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,630.00 | GBX | 91,204 | 335,935 |
18-Mar-24 | 15-Mar-24 | Exercise of Option | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 555.00 | GBX | 15,444 | 335,935 |
Indivior is working to change patients lives by developing medicines to treat addiction and serious mental illnesses.